Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
380 studies found for:    PROSTATIC HYPERPLASIA, BENIGN
Show Display Options
Rank Status Study
1 Completed
Has Results
Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
Conditions: Benign Prostatic Hyperplasia;   Prostatic Hyperplasia
Interventions: Drug: Dutasteride 0.5mg capsule;   Drug: Dutasteride matched placebo
2 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
3 Completed Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia
Conditions: Benign Prostatic Hyperplasia;   Prostatic Hyperplasia
Interventions: Drug: GI198745 0.05mg;   Drug: GI198745 0.5mg;   Drug: GI198745 2.5mg
4 Completed Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS
Conditions: Benign Prostatic Hyperplasia;   Prostatic Hyperplasia
Interventions: Procedure: IPSS Questionnaire;   Procedure: EQ-5D Questionnaire
5 Completed
Has Results
Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Tadalafil;   Drug: Placebo
6 Completed Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Levitra (Vardenafil, BAY38-9456);   Drug: Placebo
7 Completed Saw Palmetto Extract in Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Saw Palmetto
8 Recruiting Prostate Embolization for Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Procedure: Prostatic Embolization;   Drug: Embosphere® Microspheres
9 Completed
Has Results
A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
Conditions: Nocturia;   Prostatic Hyperplasia
Intervention: Drug: silodosin
10 Not yet recruiting Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia
Conditions: Prostate;   Ejaculation;   Benign Prostatic Hyperplasia
Intervention: Procedure: Search retrograde ejaculation
11 Completed Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Doxazosin
12 Completed A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Behavioral: the Digital Repetitive Infrapubic Pressure maneuver
13 Completed
Has Results
A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization
Condition: Benign Prostatic Hyperplasia
Intervention: Device: GreenLight HPS
14 Recruiting Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia (BPH)
Intervention: Device: Prostate Artery Embolization
15 Active, not recruiting Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Condition: Benign Prostatic Hyperplasia (BPH)
Intervention: Device: Vortx Rx - Histotripsy BPH Device
16 Completed
Has Results
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Silodosin;   Other: Placebo
17 Not yet recruiting Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.
Conditions: Overactive Bladder;   Benign Prostatic Hyperplasia
Interventions: Drug: Mirabegron;   Drug: Tamsulosin
18 Completed Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Early combination therapy;   Drug: Delayed combination therapy
19 Completed
Has Results
The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Silodosin
20 Completed Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Silodosin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years